| UniProt ID | ALS_HUMAN | |
|---|---|---|
| UniProt AC | P35858 | |
| Protein Name | Insulin-like growth factor-binding protein complex acid labile subunit | |
| Gene Name | IGFALS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 605 | |
| Subcellular Localization | Secreted, extracellular space. | |
| Protein Description | Involved in protein-protein interactions that result in protein complexes, receptor-ligand binding or cell adhesion.. | |
| Protein Sequence | MALRKGGLALALLLLSWVALGPRSLEGADPGTPGEAEGPACPAACVCSYDDDADELSVFCSSRNLTRLPDGVPGGTQALWLDGNNLSSVPPAAFQNLSSLGFLNLQGGQLGSLEPQALLGLENLCHLHLERNQLRSLALGTFAHTPALASLGLSNNRLSRLEDGLFEGLGSLWDLNLGWNSLAVLPDAAFRGLGSLRELVLAGNRLAYLQPALFSGLAELRELDLSRNALRAIKANVFVQLPRLQKLYLDRNLIAAVAPGAFLGLKALRWLDLSHNRVAGLLEDTFPGLLGLRVLRLSHNAIASLRPRTFKDLHFLEELQLGHNRIRQLAERSFEGLGQLEVLTLDHNQLQEVKAGAFLGLTNVAVMNLSGNCLRNLPEQVFRGLGKLHSLHLEGSCLGRIRPHTFTGLSGLRRLFLKDNGLVGIEEQSLWGLAELLELDLTSNQLTHLPHRLFQGLGKLEYLLLSRNRLAELPADALGPLQRAFWLDVSHNRLEALPNSLLAPLGRLRYLSLRNNSLRTFTPQPPGLERLWLEGNPWDCGCPLKALRDFALQNPSAVPRFVQAICEGDDCQPPAYTYNNITCASPPEVVGLDLRDLSEAHFAPC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 32 | O-linked_Glycosylation | LEGADPGTPGEAEGP CCCCCCCCCCCCCCC | 33.24 | OGP | |
| 64 | N-linked_Glycosylation | SVFCSSRNLTRLPDG EEEECCCCCCCCCCC | 47.95 | UniProtKB CARBOHYD | |
| 85 | N-linked_Glycosylation | ALWLDGNNLSSVPPA EEEECCCCCCCCCCH | 46.99 | UniProtKB CARBOHYD | |
| 96 | N-linked_Glycosylation | VPPAAFQNLSSLGFL CCCHHHCCHHHCCCE | 35.12 | UniProtKB CARBOHYD | |
| 195 | Phosphorylation | AAFRGLGSLRELVLA HHHCCCCCHHHHHHH | 29.33 | 24719451 | |
| 304 | Phosphorylation | LSHNAIASLRPRTFK HCHHHHHHCCCCCHH | 20.85 | 24719451 | |
| 342 | Phosphorylation | EGLGQLEVLTLDHNQ CCCCEEEEEECCHHH | 7.23 | 24719451 | |
| 368 | N-linked_Glycosylation | LTNVAVMNLSGNCLR CCCEEEEECCCCHHH | 25.18 | 16335952 | |
| 407 | Phosphorylation | RIRPHTFTGLSGLRR CCCCCCCCCCHHHHH | 38.07 | - | |
| 410 | Phosphorylation | PHTFTGLSGLRRLFL CCCCCCCHHHHHHHC | 36.81 | 24719451 | |
| 510 | Phosphorylation | APLGRLRYLSLRNNS HHHHHHHHHHHCCCC | 12.77 | 24719451 | |
| 512 | Phosphorylation | LGRLRYLSLRNNSLR HHHHHHHHHCCCCCC | 19.15 | 24719451 | |
| 515 | N-linked_Glycosylation | LRYLSLRNNSLRTFT HHHHHHCCCCCCCCC | 47.97 | 16335952 | |
| 517 | Phosphorylation | YLSLRNNSLRTFTPQ HHHHCCCCCCCCCCC | 23.83 | 24719451 | |
| 548 | Phosphorylation | GCPLKALRDFALQNP CCCHHHHHHHHHHCC | 41.69 | 24719451 | |
| 550 | Phosphorylation | PLKALRDFALQNPSA CHHHHHHHHHHCCCH | 6.21 | 24719451 | |
| 555 | Phosphorylation | RDFALQNPSAVPRFV HHHHHHCCCHHHHHH | 15.65 | 24719451 | |
| 580 | N-linked_Glycosylation | PPAYTYNNITCASPP CCCEEECCEEECCCC | 22.12 | UniProtKB CARBOHYD |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ALS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ALS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ALS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| IBP3_HUMAN | IGFBP3 | physical | 9497324 | |
| IBP5_HUMAN | IGFBP5 | physical | 9497324 | |
| IBP3_HUMAN | IGFBP3 | physical | 9446566 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615961 | Acid-labile subunit deficiency (ACLSD) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-368, AND MASSSPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-368 AND ASN-515, AND MASSSPECTROMETRY. | |